NASDAQ · Financial Statements
Acurx Pharmaceuticals, Inc. (ACXP) Financial Statements
$1.27
NASDAQ: ACXP
Market Cap $5.46M
Overview Financials Dividend Acurx Pharmaceuticals, Inc. most recently reported annual revenue of $0, net profit of $-8.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $0 $0 $0 $0 $0 Operating Profit $-13.0M $-12.0M $-15.0M $-14.0M $-8.0M Net Profit $-13.0M $-12.0M $-15.0M $-14.0M $-8.0M EPS $-24.96 $-22.36 $-23.01 $-17.59 $-5.32 Op Margin — — — — —
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $13.0M $9.0M $8.0M $4.0M $8.0M Total Liabilities $1.0M $2.0M $3.0M $3.0M $2.0M Cash $13.0M $9.0M $7.0M $4.0M $8.0M Borrowings $0 $0 $0 $0 $0
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-5.0M $-8.0M $-10.0M $-10.0M $-7.0M Investing Cash Flow $0 $0 $0 $0 $0 Financing Cash Flow $0 $0 $2.0M $0 $0 Net Cash Flow $10.0M $-4.0M $-2.0M $-4.0M $4.0M Free Cash Flow $-5.0M $-8.0M $-10.0M $-10.0M $-7.0M
Valuation & Return Ratios
Metric Value PEG Ratio 0.00 EV / EBITDA 0.69 FCF Yield -113.28% Quick Ratio 3.88 Interest Coverage 0.00 Return 1Y -79.84% Return 3Y -95.91% Return 5Y -98.55%
Screens featuring this stock